UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Exposing rodents to a combination of tobacco smoke and lipopolysaccharide results in an exaggerated inflammatory response in the lung

British journal of pharmacology, 2010-08, Vol.160 (8), p.1985-1996

2010

Volltextzugriff (PDF)

Theophylline and selective phosphodiesterase inhibitors as anti-inflammatory drugs in the treatment of bronchial asthma

The European respiratory journal, 1995-06, Vol.8 (6), p.996-1000

1995

Volltextzugriff (PDF)

Identification and quantification of phosphodiesterase 4 subtypes in CD4 and CD8 lymphocytes from healthy and asthmatic subjects

British journal of pharmacology, 2001-07, Vol.133 (5), p.722-729

2001

Volltextzugriff (PDF)

The effect of selective phosphodiesterase 3 and 4 isoenzyme inhibitors and established anti‐asthma drugs on inflammatory cell activation

British journal of pharmacology, 1996-11, Vol.119 (6), p.1255-1261

1996

Volltextzugriff (PDF)

Characterisation of a refined rat model of respiratory infection with Pseudomonas aeruginosa and the effect of ciprofloxacin

Journal of cystic fibrosis, 2011-05, Vol.10 (3), p.166-174

2011

Volltextzugriff (PDF)

Differential effect of phosphodiesterase 4 inhibitors on the proliferation of human peripheral blood mononuclear cells from normals and subjects with atopic dermatitis

British journal of pharmacology, 1995-12, Vol.116 (8), p.3169-3174

1995

Volltextzugriff (PDF)

Acute versus chronic administration of phosphodiesterase inhibitors on allergen‐induced pulmonary cell influx in sensitized guinea‐pigs

British journal of pharmacology, 1995-01, Vol.114 (1), p.93-98

1995

Volltextzugriff (PDF)

Anti-inflammatory effects of theophylline and selective phosphodiesterase inhibitors

Clinical and experimental allergy, 1996-03, Vol.26 (s2), p.2-9

1996

Volltextzugriff (PDF)

D37 COPD: DEVELOPMENTAL THERAPEUTICS: A Phase I, Randomised, Double Blind, Placebo Controlled, Study To Assess The Safety, Tolerability And Pharmacokinetics Of Multiple Inhaled Doses Of Rpl554 Administered By Nebuliser To Healthy Male Subjects And Stable COPD Patients

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

A31 ASTHMA THERAPY: GLUCOCORTICOIDS AND BEYOND: Rpl554, A First-In-Class Dual Phosphodiesterase (pde)3/4 Inhibitor, Is Equi-Effective As A Bronchodilator To Maximal Doses Of Salbutamol In Asthmatics But With Fewer Adverse Events

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

D37 COPD: DEVELOPMENTAL THERAPEUTICS: A Phase I, Randomised, Double Blind, Placebo Controlled, Study To Assess The Safety, Tolerability And Pharmacokinetics Of Single Inhaled Doses Of The Dual Phosphodiesterase 3/4 (pde3/4) Inhibitor Rpl554 Administered By Nebuliser To Healthy Male Subjects

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

Evidence to suggest that the phosphodiesterase 4 isoenzyme is present and involved in the proliferation of umbilical cord blood mononuclear cells

Clinical and experimental allergy, 2000-05, Vol.30 (5), p.706-712

2000

Volltextzugriff (PDF)

Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials

The lancet respiratory medicine, 2013-11, Vol.1 (9), p.714-727

2013

Volltextzugriff (PDF)

Possible contribution of prostaglandin E2 to the antiproliferative effect of phosphodiesterase 4 inhibitors in human mononuclear cells

Biochemical pharmacology, 1999-11, Vol.58 (9), p.1487-1495

1999

Volltextzugriff (PDF)

Effects of dexamethasone on airway hyper‐responsiveness to the adenosine A1 receptor agonist cyclo‐pentyl adenosine in an allergic rabbit model

British journal of pharmacology, 1999-03, Vol.126 (6), p.1513-1521

1999

Volltextzugriff (PDF)

Neutral sphingomyelinase-2, acid sphingomyelinase, and ceramide levels in COPD patients compared to controls

International journal of chronic obstructive pulmonary disease, 2016-01, Vol.11 (1), p.2139-2147

2016

Volltextzugriff (PDF)

PDE4 inhibition: a novel approach for the treatment of inflammatory bowel disease

Trends in pharmacological sciences (Regular ed.), 2004-08, Vol.25 (8), p.430-436

2004

Volltextzugriff (PDF)

Immunomodulatory actions of xanthines and isoenzyme selective phosphodiesterase inhibitors

Monaldi archives for chest disease, 1995-08, Vol.50 (4), p.286

1995

Volltextzugriff (PDF)

TRP channels: Emerging targets for respiratory disease

Pharmacology & therapeutics (Oxford), 2011-06, Vol.130 (3), p.371-384

2011

Volltextzugriff (PDF)

Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells

Respiratory research, 2006-01, Vol.7 (1), p.9-9, Article 9

2006

Volltextzugriff (PDF)

The Effect of Selective Phosphodiesterase Inhibitors in Comparison with other Anti-asthma Drugs on Allergen-induced Eosinophilia in Guinea-pig Airways

Pulmonary pharmacology (Edinburgh), 1995-02, Vol.8 (1), p.37-42

1995

Volltextzugriff (PDF)

PDE4 Inhibitors - A Review of the Current Field

Progress in Medicinal Chemistry, 2009, Vol.47, p.37-74

2009

Volltextzugriff (PDF)

Macroscopic, microscopic and biochemical characterisation of spontaneous colitis in a transgenic mouse, deficient in the multiple drug resistance 1a gene

British journal of pharmacology, 2004-11, Vol.143 (5), p.590-598

2004

Volltextzugriff (PDF)

Effect of Isoenzyme Selective Phosphodiesterase Inhibitors on the Proliferation of Murine Thymus and Spleen Cells

Pulmonary pharmacology (Edinburgh), 1996-02, Vol.9 (1), p.35-41

1996

Volltextzugriff (PDF)

Hypoxia Amplifies the Proliferative Capacity of Distal Human Pulmonary Artery Smooth-Muscle Cells

Chest, 2005-12, Vol.128 (6), p.600S-601S

2005

Volltextzugriff (PDF)

1 – 25 von 249

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(226)
Mit Volltextzugriff
(218)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(125)
Life Sciences & Biomedicine
(99)
Humans
(75)
Biological And Medical Sciences
(65)
Medical Sciences
(55)
Male
(51)
Physics
(49)
Female
(47)
Animals
(41)
High Energy Physics - Experiment
(37)
Middle Aged
(26)
Adult
(25)
Physical Sciences
(24)
Pharmacology & Pharmacy
(19)
Respiratory System
(17)
Surgery
(16)
Rats
(15)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(15)
General & Internal Medicine
(13)
Immunology
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Exposing rodents to a combination of tobacco smoke and lipopolysaccharide results in an exaggerated inflammatory response in the lung

Theophylline and selective phosphodiesterase inhibitors as anti-inflammatory drugs in the treatment of bronchial asthma

Identification and quantification of phosphodiesterase 4 subtypes in CD4 and CD8 lymphocytes from healthy and asthmatic subjects

The effect of selective phosphodiesterase 3 and 4 isoenzyme inhibitors and established anti‐asthma drugs on inflammatory cell activation

Characterisation of a refined rat model of respiratory infection with Pseudomonas aeruginosa and the effect of ciprofloxacin

Differential effect of phosphodiesterase 4 inhibitors on the proliferation of human peripheral blood mononuclear cells from normals and subjects with atopic dermatitis

Acute versus chronic administration of phosphodiesterase inhibitors on allergen‐induced pulmonary cell influx in sensitized guinea‐pigs

Anti-inflammatory effects of theophylline and selective phosphodiesterase inhibitors

D37 COPD: DEVELOPMENTAL THERAPEUTICS: A Phase I, Randomised, Double Blind, Placebo Controlled, Study To Assess The Safety, Tolerability And Pharmacokinetics Of Multiple Inhaled Doses Of Rpl554 Administered By Nebuliser To Healthy Male Subjects And Stable COPD Patients

A31 ASTHMA THERAPY: GLUCOCORTICOIDS AND BEYOND: Rpl554, A First-In-Class Dual Phosphodiesterase (pde)3/4 Inhibitor, Is Equi-Effective As A Bronchodilator To Maximal Doses Of Salbutamol In Asthmatics But With Fewer Adverse Events

D37 COPD: DEVELOPMENTAL THERAPEUTICS: A Phase I, Randomised, Double Blind, Placebo Controlled, Study To Assess The Safety, Tolerability And Pharmacokinetics Of Single Inhaled Doses Of The Dual Phosphodiesterase 3/4 (pde3/4) Inhibitor Rpl554 Administered By Nebuliser To Healthy Male Subjects

Evidence to suggest that the phosphodiesterase 4 isoenzyme is present and involved in the proliferation of umbilical cord blood mononuclear cells

Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials

Possible contribution of prostaglandin E2 to the antiproliferative effect of phosphodiesterase 4 inhibitors in human mononuclear cells

Effects of dexamethasone on airway hyper‐responsiveness to the adenosine A1 receptor agonist cyclo‐pentyl adenosine in an allergic rabbit model

Neutral sphingomyelinase-2, acid sphingomyelinase, and ceramide levels in COPD patients compared to controls

PDE4 inhibition: a novel approach for the treatment of inflammatory bowel disease

Immunomodulatory actions of xanthines and isoenzyme selective phosphodiesterase inhibitors

TRP channels: Emerging targets for respiratory disease

Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells

The Effect of Selective Phosphodiesterase Inhibitors in Comparison with other Anti-asthma Drugs on Allergen-induced Eosinophilia in Guinea-pig Airways

PDE4 Inhibitors - A Review of the Current Field

Macroscopic, microscopic and biochemical characterisation of spontaneous colitis in a transgenic mouse, deficient in the multiple drug resistance 1a gene

Effect of Isoenzyme Selective Phosphodiesterase Inhibitors on the Proliferation of Murine Thymus and Spleen Cells

Hypoxia Amplifies the Proliferative Capacity of Distal Human Pulmonary Artery Smooth-Muscle Cells

Suchergebnisse filtern